Published in Infect Immun on January 01, 1997
Identification and characterization of a novel heme-associated cell surface protein made by Streptococcus pyogenes. Infect Immun (2002) 1.79
Review of meningococcal group B vaccines. Clin Infect Dis (2010) 1.58
Iron transport systems in Neisseria meningitidis. Microbiol Mol Biol Rev (2004) 1.58
Structural basis for iron piracy by pathogenic Neisseria. Nature (2012) 1.50
ABC transporter FtsABCD of Streptococcus pyogenes mediates uptake of ferric ferrichrome. BMC Microbiol (2005) 1.28
Antigenic and sequence diversity in gonococcal transferrin-binding protein A. Infect Immun (2000) 1.09
Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex. Clin Diagn Lab Immunol (1997) 1.06
The transferrin-iron import system from pathogenic Neisseria species. Mol Microbiol (2012) 0.97
Identification of human transferrin-binding sites within meningococcal transferrin-binding protein B. J Bacteriol (1997) 0.96
Identification of TbpA residues required for transferrin-iron utilization by Neisseria gonorrhoeae. Infect Immun (2008) 0.96
Analysis of the immunological responses to transferrin and lactoferrin receptor proteins from Moraxella catarrhalis. Infect Immun (1999) 0.94
Development and characterization of protective Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin and comparison with other subunit and commercial vaccines. Clin Vaccine Immunol (2010) 0.92
Vaccination of mice with gonococcal TbpB expressed in vivo from Venezuelan equine encephalitis viral replicon particles. Infect Immun (2006) 0.92
Role of transferrin receptor from a Neisseria meningitidis tbpB isotype II strain in human transferrin binding and virulence. Infect Immun (2004) 0.92
Variation and molecular evolution of HmbR, the Neisseria meningitidis haemoglobin receptor. Microbiology (2010) 0.89
Evidence for a common gene pool and frequent recombinational exchange of the tbpBA operon in Mannheimia haemolytica, Mannheimia glucosida and Bibersteinia trehalosi. Microbiology (2010) 0.84
Nonbinding site-directed mutants of transferrin binding protein B exhibit enhanced immunogenicity and protective capabilities. Infect Immun (2014) 0.84
Transferrin-binding protein B of Neisseria meningitidis: sequence-based identification of the transferrin-Binding site confirmed by site-directed mutagenesis. J Bacteriol (2004) 0.82
ZnuD, a potential candidate for a simple and universal Neisseria meningitidis vaccine. Infect Immun (2013) 0.81
Slam is an outer membrane protein that is required for the surface display of lipidated virulence factors in Neisseria. Nat Microbiol (2016) 0.80
The structure of lactoferrin-binding protein B from Neisseria meningitidis suggests roles in iron acquisition and neutralization of host defences. Acta Crystallogr F Struct Biol Commun (2014) 0.78
Purified meningococcal transferrin-binding protein B interacts with a secondary, strain-specific, binding site in the N-terminal lobe of human transferrin. Biochem J (1999) 0.78
Investigation into the Antigenic Properties and Contributions to Growth in Blood of the Meningococcal Haemoglobin Receptors, HpuAB and HmbR. PLoS One (2015) 0.75
Improvement of immunogenicity of meningococcal lipooligosaccharide by coformulation with lipidated transferrin-binding protein B in liposomes: implications for vaccine development. Clin Vaccine Immunol (2012) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A (1985) 68.48
Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet (1991) 6.26
Evoked potentials: computer-automated threshold-tracking procedure using an objective detection criterion. Ear Hear (1987) 5.89
Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci U S A (1986) 5.39
Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers. J Gen Microbiol (1986) 5.05
Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis (1972) 4.54
Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis (1993) 4.02
Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. J Clin Invest (1979) 3.61
Identification and characterization of the transferrin receptor from Neisseria meningitidis. Mol Microbiol (1988) 3.49
Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann (1991) 3.32
Gonococcal transferrin-binding protein 1 is required for transferrin utilization and is homologous to TonB-dependent outer membrane receptors. J Bacteriol (1992) 3.21
Allelic polymorphism and site-specific recombination in the opc locus of Neisseria meningitidis. Mol Microbiol (1996) 3.00
The Neisseria meningitidis haemoglobin receptor: its role in iron utilization and virulence. Mol Microbiol (1995) 2.52
Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet (1992) 2.52
Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis. J Infect Dis (1973) 2.47
Identification and characterization of the human lactoferrin-binding protein from Neisseria meningitidis. Infect Immun (1988) 2.47
Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization. J Bacteriol (1994) 2.32
Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2. Gene (1993) 2.19
Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect Immun (1994) 1.96
Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986. J Infect Dis (1990) 1.96
HmbR outer membrane receptors of pathogenic Neisseria spp.: iron-regulated, hemoglobin-binding proteins with a high level of primary structure conservation. J Bacteriol (1996) 1.90
Immunization of pigs against Actinobacillus pleuropneumoniae with two recombinant protein preparations. Vaccine (1992) 1.81
Identification of an iron-regulated 37,000-dalton protein in the cell envelope of Neisseria gonorrhoeae. Infect Immun (1984) 1.79
Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals. Vaccine (1993) 1.75
Binding and surface exposure characteristics of the gonococcal transferrin receptor are dependent on both transferrin-binding proteins. J Bacteriol (1996) 1.70
Cloning and expression of a transferrin-binding protein from Actinobacillus pleuropneumoniae. Infect Immun (1992) 1.68
Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines. Infect Immun (1995) 1.60
Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination. Infect Immun (1989) 1.59
A pleiotropic iron-uptake mutant of Neisseria meningitidis lacks a 70-kilodalton iron-regulated protein. Infect Immun (1988) 1.51
Identification of an iron-regulated outer membrane protein of Neisseria meningitidis involved in the utilization of hemoglobin complexed to haptoglobin. J Bacteriol (1995) 1.51
Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Infect Immun (1994) 1.51
Outer membrane protein serosubtyping of Neisseria meningitidis. Eur J Clin Microbiol Infect Dis (1988) 1.41
Common antigenic domains in transferrin-binding protein 2 of Neisseria meningitidis, Neisseria gonorrhoeae, and Haemophilus influenzae type b. Infect Immun (1992) 1.38
Expression of Neisseria meningitidis iron-regulated outer membrane proteins, including a 70-kilodalton transferrin receptor, and their potential for use as vaccines. Infect Immun (1990) 1.33
Identification of two major families of transferrin receptors among Neisseria meningitidis strains based on antigenic and genomic features. FEMS Microbiol Lett (1993) 1.23
Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential. Vaccine (1995) 1.21
Characterization of a highly structured domain in Tbp2 from Neisseria meningitidis involved in binding to human transferrin. J Bacteriol (1994) 1.20
The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains. Vaccine (1996) 1.18
Cloning and expression of the Haemophilus influenzae transferrin receptor genes. Mol Microbiol (1996) 1.18
Antigenic and molecular heterogeneity of the transferrin-binding protein of Neisseria meningitidis. FEMS Microbiol Lett (1990) 1.14
Diversity of the transferrin-binding protein Tbp2 of Neisseria meningitidis. Gene (1995) 1.07
Transferrin receptors of Neisseria meningitidis: promising candidates for a broadly cross-protective vaccine. J Med Microbiol (1996) 1.06
Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease. NIPH Ann (1991) 1.05
Variable sequences in a mosaic-like domain of meningococcal tbp2 encode immunoreactive epitopes. FEMS Microbiol Lett (1995) 1.02
Localization of the meningococcal receptors for human transferrin. Infect Immun (1993) 1.00
Immunogenicity and antigenic heterogeneity of a human transferrin-binding protein in Neisseria meningitidis. Infect Immun (1992) 1.00
Antibody response after immunization of Brazilian children with serogroup C meningococcal polysaccharide noncovalently complexed with outer membrane proteins. Braz J Med Biol Res (1995) 0.83
Production of lipidated meningococcal transferrin binding protein 2 in Escherichia coli. Protein Expr Purif (1995) 0.82
Molecular immunological analysis of meningococcal class 1 outer membrane protein and lipopolysaccharide. Trans R Soc Trop Med Hyg (1991) 0.77
Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A (1998) 39.20
Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol (1986) 24.31
Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis--one species on the basis of genetic evidence. Appl Environ Microbiol (2000) 7.87
Genetic diversity and temporal variation in the E. coli population of a human host. Genetics (1981) 7.35
Enzyme polymorphism and genetic population structure in Escherichia coli and Shigella. J Gen Microbiol (1983) 7.28
Population genetics of pathogenic bacteria. Microb Pathog (1987) 5.59
Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci U S A (1986) 5.39
Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol (1987) 5.30
Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers. J Gen Microbiol (1986) 5.05
Genetic diversity in relation to serotype in Escherichia coli. Infect Immun (1985) 4.11
Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis (1993) 4.02
Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China. Infect Immun (1992) 4.02
Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clin Infect Dis (1993) 3.63
Genetic relationships and clonal structure of strains of Escherichia coli causing neonatal septicemia and meningitis. Infect Immun (1986) 3.57
Phenotypic and genotypic changes in a new clone complex of Neisseria meningitidis causing disease in The Netherlands, 1958-1990. J Infect Dis (1994) 3.50
Genetic diversity and relationships among strains of Escherichia coli in the intestine and those causing urinary tract infections. Prog Allergy (1983) 3.12
Allelic polymorphism and site-specific recombination in the opc locus of Neisseria meningitidis. Mol Microbiol (1996) 3.00
Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis. Proc Natl Acad Sci U S A (2001) 2.66
Genotypic Diversity among Bacillus cereus and Bacillus thuringiensis Strains. Appl Environ Microbiol (1994) 2.58
Leptin secretion and leptin receptor in the human stomach. Gut (2000) 2.46
Genetic structure of population of Bacillus cereus and B. thuringiensis isolates associated with periodontitis and other human infections. J Clin Microbiol (2000) 2.39
Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J Clin Microbiol (1991) 2.38
Genetic diversity of Bacillus cereus/B. thuringiensis isolates from natural sources. Curr Microbiol (1998) 2.21
Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2. Gene (1993) 2.19
Distribution of multilocus genotypes of Escherichia coli within and between host families. J Hyg (Lond) (1984) 2.10
Sialic acid content and proteolytic activity in gastric juice in humans. An approach for appreciating mucus glycoprotein erosion. Dig Dis Sci (1988) 2.06
Genetic relationships and clonal population structure of serotype 2 strains of Neisseria meningitidis. Infect Immun (1987) 2.04
Difference in structure between type b and nontypable Haemophilus influenzae populations. Infect Immun (1986) 1.84
Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs. Eur J Clin Microbiol Infect Dis (2005) 1.80
Ongoing group B Neisseria meningitidis epidemic in São Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex. J Clin Microbiol (1992) 1.79
Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Trop Med Int Health (1998) 1.78
Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals. Vaccine (1993) 1.75
False-positive somatostatin receptor scintigraphy due to an accessory spleen. J Nucl Med (1997) 1.67
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun (1993) 1.62
Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines. Infect Immun (1995) 1.60
Multicentre prospective controlled study of Barrett's oesophagus and colorectal adenomas. Groupe d'Etude de l'Oesophage de Barrett. Lancet (1995) 1.59
Injectional anthrax in a heroin skin-popper. Lancet (2000) 1.58
Molecular epidemiology of Mycobacterium tuberculosis in Norway. J Clin Microbiol (2001) 1.54
[How to express results of 24-hour gastric pH measurement? Choice of a mode of expression in 27 healthy subjects]. Gastroenterol Clin Biol (1989) 1.51
Genetic diversity of penicillin G-resistant Neisseria meningitidis from Spain. Infect Immun (1989) 1.50
Apparent differences in antimicrobial susceptibility as a consequence of national guidelines. Clin Microbiol Infect (2000) 1.50
Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa. J Infect Dis (2009) 1.47
Characterization of epidemic and nonepidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden. J Clin Microbiol (1990) 1.45
Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J Clin Microbiol (2000) 1.41
Normal serum gastrin concentration in gastrinoma. Lancet (1995) 1.39
Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Int J Tuberc Lung Dis (2002) 1.37
M or M-like protein gene polymorphisms in human group G streptococci. J Clin Microbiol (1995) 1.31
Expression of an inaccessible P1.7 subtype epitope on meningococcal class 1 proteins. J Med Microbiol (1993) 1.31
Application of multilocus enzyme gel electrophoresis to Haemophilus influenzae. Infect Immun (1986) 1.30
Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut (1991) 1.28
Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome. Ann Surg (1981) 1.27
A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine. Microb Pathog (1993) 1.25
Contamination pattern of Listeria monocytogenes and other Listeria spp. in a salmon slaughterhouse and smoked salmon processing plant. Int J Food Microbiol (1995) 1.24
Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer (1993) 1.23
Identification of two major families of transferrin receptors among Neisseria meningitidis strains based on antigenic and genomic features. FEMS Microbiol Lett (1993) 1.23
Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology (2001) 1.22
Are sphincter defects the cause of anal incontinence after vaginal delivery? Results of a prospective study. Dis Colon Rectum (2000) 1.22
Regression of inflammatory pseudotumor of the liver under conservative therapy. Dig Dis Sci (1995) 1.21
Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94. Epidemiol Infect (1996) 1.20
Resident colonic Escherichia coli strains frequently display uropathogenic characteristics. J Infect Dis (1992) 1.19
Characteristics of serogroup A Neisseria meningitidis responsible for an epidemic in Ethiopia, 1988-89. Scand J Infect Dis (1990) 1.18
Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med (1997) 1.15
Genetic variation among Staphylococcus aureus strains from Norwegian bulk milk. Appl Environ Microbiol (2005) 1.14
Randomly amplified polymorphic DNA genotyping of serogroup A meningococci yields results similar to those obtained by multilocus enzyme electrophoresis and reveals new genotypes. J Clin Microbiol (1998) 1.14
Structure and function of repetitive sequence elements associated with a highly polymorphic domain of the Neisseria meningitidis PilQ protein. Mol Microbiol (1998) 1.13
Identification of nasopharyngeal carriage of an outbreak strain of Neisseria meningitidis by pulsed-field gel electrophoresis versus phenotypic methods. J Med Microbiol (1998) 1.13
Molecular polymorphism and epidemiology of Neisseria meningitidis immunoglobulin A1 proteases. Proc Natl Acad Sci U S A (1992) 1.13
Cimetidine treatment of acute and chronic Zollinger-Ellison syndrome. World J Surg (1979) 1.11
Emergence of a new virulent clone within the electrophoretic type 5 complex of serogroup B meningococci in Norway. Clin Diagn Lab Immunol (1995) 1.10
Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome. Surgery (1995) 1.10
Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients. Gut (1992) 1.10
Current approach to the management of tumoral process in patients with gastrinoma. World J Surg (1986) 1.09
Multivariate analysis of pathophysiological factors in reflux oesophagitis. Gut (1997) 1.08
Comparison of epidemiological marker methods for identification of Salmonella typhimurium isolates from an outbreak caused by contaminated chocolate. J Clin Microbiol (1989) 1.08
Diversity of the transferrin-binding protein Tbp2 of Neisseria meningitidis. Gene (1995) 1.07
Diagnosis and treatment of Zollinger-Ellison syndrome. Baillieres Clin Gastroenterol (1988) 1.07
Characterization of Neisseria meningitidis serogroup A strains from an outbreak in France by serotype, serosubtype, multilocus enzyme genotype and outer membrane protein pattern. Eur J Clin Microbiol Infect Dis (1991) 1.07
Differences in genetic diversity of nonecapsulated Haemophilus influenzae from various diseases. Microbiology (1997) 1.06
Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex. Clin Diagn Lab Immunol (1997) 1.06
Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world. Epidemiol Infect (2000) 1.06
Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants. Antimicrob Agents Chemother (2006) 1.04
Assessment of Helicobacter pylori gene expression within mouse and human gastric mucosae by real-time reverse transcriptase PCR. Infect Immun (2001) 1.04
Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa. Gastroenterology (1993) 1.04
Disseminated Mycobacterium celatum (type 3) infection in a domestic ferret (Mustela putorius furo). Vet Pathol (2001) 1.04